Chroniject™ Technology: A Solution to Long-Acting Injectable Formulation and Scale-Up Challenges

Session details:

1. Tunable Drug Release Across Diverse Applications: Oakwood’s Chroniject™ technology provides a flexible long-acting injectable platform designed to support a wide range of molecules and therapeutic applications. The session will demonstrate how the platform can be tailored to achieve efficacious release profiles ranging from as short as two days to as long as one year, helping attendees understand how formulation parameters can be optimized to meet specific target product profiles.
2. Scalable Formulation from Feasibility Through Commercial Manufacturing: Chroniject™ provides a platform for scaling long-acting injectable formulations while maintaining critical quality attributes throughout development. Attendees will learn how formulations can progress from initial gram-scale feasibility batches to kilogram-scale clinical and commercial manufacturing while preserving key product and performance characteristics.
3. Reducing Development and Scale-Up Challenges for Long-Acting Injectables: The session will discuss how a platform-based approach can help address common challenges associated with long-acting injectable development, including formulation optimization, reproducibility, process scale-up, and manufacturing readiness. Attendees will gain practical insight into considerations for developing a formulation and process with the end goal of successful clinical and commercial manufacturing.